Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Sun

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Urology|July 25, 2009
Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomyDavid D Xu, Sandy D Sun, Flint Wang, et al.
Journal of Clinical Anesthesia|August 25, 2009
A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomyRichard C D'Alonzo, Tong J Gan, Judd W Moul, et al.
The Journal of Urology|February 10, 2004
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
European Urology|July 1, 2008
Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomyFlorian R Schroeck, Tracey L Krupski, Leon Sun, et al.
The Journal of Urology|April 25, 2008
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancerBridget F Koontz, Vladimir Mouraviev, Jeffrey L Johnson, et al.
Cancer Research|August 9, 2003
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progressionLinda L Xu, Yinghui Shi, Gyorgy Petrovics, et al.
Urologic Oncology|December 25, 2003
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national databaseJudd W Moul, Leon Sun, Hongyu Wu, et al.
Urology|April 4, 2008
Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigenBrandon K Isariyawongse, Leon Sun, Lionel L Bañez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patientsChun-Ling Gao, Sudhir K Rawal, Leon Sun, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Urology|July 25, 2009
Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomyDavid D Xu, Sandy D Sun, Flint Wang, et al.
Journal of Clinical Anesthesia|August 25, 2009
A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomyRichard C D'Alonzo, Tong J Gan, Judd W Moul, et al.
The Journal of Urology|February 10, 2004
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
European Urology|July 1, 2008
Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomyFlorian R Schroeck, Tracey L Krupski, Leon Sun, et al.
The Journal of Urology|April 25, 2008
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomyJudd W Moul, Hongyu Wu, Leon Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancerBridget F Koontz, Vladimir Mouraviev, Jeffrey L Johnson, et al.
Cancer Research|August 9, 2003
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progressionLinda L Xu, Yinghui Shi, Gyorgy Petrovics, et al.
Urologic Oncology|December 25, 2003
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the Department of Defense (DOD) Center for Prostate Disease Research (CPDR) national databaseJudd W Moul, Leon Sun, Hongyu Wu, et al.
Urology|April 4, 2008
Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigenBrandon K Isariyawongse, Leon Sun, Lionel L Bañez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patientsChun-Ling Gao, Sudhir K Rawal, Leon Sun, et al.
Pageof 10